These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36923958)

  • 41. Digital Transformation of Cancer Care in the Era of Big Data, Artificial Intelligence and Data-Driven Interventions: Navigating the Field.
    Papachristou N; Kotronoulas G; Dikaios N; Allison SJ; Eleftherochorinou H; Rai T; Kunz H; Barnaghi P; Miaskowski C; Bamidis PD
    Semin Oncol Nurs; 2023 Jun; 39(3):151433. PubMed ID: 37137770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardio-oncology: the Nuclear Option.
    Alvarez JA; Russell RR
    Curr Cardiol Rep; 2017 Apr; 19(4):31. PubMed ID: 28315122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Importance of Primary Care in Cardio-Oncology.
    Cehic DA; Sverdlov AL; Koczwara B; Emery J; Ngo DTM; Thornton-Benko E
    Curr Treat Options Oncol; 2021 Oct; 22(12):107. PubMed ID: 34674055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Big data analysis and artificial intelligence in epilepsy - common data model analysis and machine learning-based seizure detection and forecasting.
    Chung YG; Jeon Y; Yoo S; Kim H; Hwang H
    Clin Exp Pediatr; 2022 Jun; 65(6):272-282. PubMed ID: 34844397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardio-oncology: need for novel structures.
    Michel L; Rassaf T
    Eur J Med Res; 2019 Jan; 24(1):1. PubMed ID: 30606260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy.
    Contaldi C; Montesarchio V; Catapano D; Falco L; Caputo F; D'Aniello C; Masarone D; Pacileo G
    Life (Basel); 2023 Oct; 13(10):. PubMed ID: 37895484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-coding RNAs, cancer treatment and cardiotoxicity: A triad of new hope.
    Mittal R; Krishnan M P S; Saxena R; Sampath A; Goyal B
    Cancer Treat Res Commun; 2023; 36():100750. PubMed ID: 37531735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardio-oncology imaging tools at the translational interface.
    Yaros K; Eksi B; Chandra A; Agusala K; Lehmann LH; Zaha VG
    J Mol Cell Cardiol; 2022 Jul; 168():24-32. PubMed ID: 35385715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contemporary Understandings of Cardiovascular Disease After Cancer Radiotherapy: a Focus on Ischemic Heart Disease.
    Kim L; Loccoh EC; Sanchez R; Ruz P; Anaba U; Williams TM; Slivnick J; Vallakati A; Baliga R; Ayan A; Miller ED; Addison D
    Curr Cardiol Rep; 2020 Sep; 22(11):151. PubMed ID: 32964267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Artificial intelligence (AI) and cancer prevention: the potential application of AI in cancer control programming needs to be explored in population laboratories such as COMPASS.
    Leatherdale ST; Lee J
    Cancer Causes Control; 2019 Jul; 30(7):671-675. PubMed ID: 31093860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Brazilian cardio-oncology: the 10-year experience of the Instituto do Cancer do Estado de Sao Paulo.
    Costa IBSDS; Bittar CS; Fonseca SMR; E Silva CMPD; Dos Santos Rehder MHH; Rizk SI; Cruz CBBV; Figueiredo CS; de A Andrade FT; Barberino LA; de S Costa FA; Machado LP; González TB; Almeida MPC; Fukushima JT; Kalil Filho R; Hajjar LA
    BMC Cardiovasc Disord; 2020 Apr; 20(1):206. PubMed ID: 32345217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Role of Multimodality Cardiac Imaging in Patients Undergoing Cancer Treatment.
    Wengrofsky P; Feldman S
    Curr Cardiol Rep; 2023 Jan; 25(1):1-8. PubMed ID: 36527535
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of Cardiovascular Biomarkers in the Risk Stratification, Monitoring, and Management of Patients with Cancer.
    Hoeger CW; Hayek SS
    Cardiol Clin; 2019 Nov; 37(4):505-523. PubMed ID: 31587791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular Complications of Pan-Cancer Therapies: The Need for Cardio-Oncology.
    Chen M; Xue J; Wang M; Yang J; Chen T
    Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37297017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiac Biomarkers for the Detection and Management of Cancer Therapy-Related Cardiovascular Toxicity.
    Zhang X; Sun Y; Zhang Y; Fang F; Liu J; Xia Y; Liu Y
    J Cardiovasc Dev Dis; 2022 Oct; 9(11):. PubMed ID: 36354771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of Imaging in Cardio-Oncology.
    Avelar E; Strickland CR; Rosito G
    Curr Treat Options Cardiovasc Med; 2017 Jun; 19(6):46. PubMed ID: 28474324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity.
    O'Hare M; Murphy K; Mookadam F; Sharma A; Lee H
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):519-27. PubMed ID: 25864865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strategies to Prevent Cardiotoxicity.
    Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
    Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiotherapy-Induced Cardiotoxicity: The Role of Multimodality Cardiovascular Imaging.
    Podlesnikar T; Berlot B; Dolenc J; Goričar K; Marinko T
    Front Cardiovasc Med; 2022; 9():887705. PubMed ID: 35966531
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.
    Parent S; Pituskin E; Paterson DI
    Can J Cardiol; 2016 Jul; 32(7):847-51. PubMed ID: 27343743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.